Your account is not claimed yet. You can sign up with ORCID to claim your account.

David Otaegui

ResearcherID Loop profile Scopus Author ID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

PloS one

Biomedicines

F1000Research

Journal of clinical medicine

Biodonostia Research Institute

University of the Basque Country (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Biodonostia Research Institute

Spain

Group leader :: Multiple sclerosis Group

Education History

University of the Basque Country Jan 1o 2002 - Jun 10o 2007

Spain

PHD :: Genetics, Antropology and animal Physiology

Publications

Andrés Roncancio-Clavijo, Miriam Gorostidi-Aicua, Ainhoa Alberro, Andrea Iribarren-Lopez, Ray Butler, Raúl Lopez, Jose Antonio Iribarren, Diego Clemente, Jose María Marimon, Javier Basterrechea, Bruno Martínez, Alvaro Prada, David Otaegui
Early biochemical analysis of COVID-19 patients helps severity prediction. PloS one 18 (5) (2023)
Andrés Roncancio-Clavijo, Miriam Gorostidi-Aicua, Ainhoa Alberro, Andrea Iribarren-Lopez, Ray Butler, Raúl Lopez, Jose Antonio Iribarren, Diego Clemente, Jose María Marimon, Javier Basterrechea, Bruno Martínez, Alvaro Prada, David Otaegui
Early biochemical analysis of COVID-19 patients helps severity prediction. PloS one 18 (5) (2023)
Andrés Roncancio-Clavijo, Miriam Gorostidi-Aicua, Ainhoa Alberro, Andrea Iribarren-Lopez, Ray Butler, Raúl Lopez, Jose Antonio Iribarren, Diego Clemente, Jose María Marimon, Javier Basterrechea, Bruno Martínez, Alvaro Prada, David Otaegui
Early biochemical analysis of COVID-19 patients helps severity prediction. PloS one 18 (5) (2023)
Ainhoa Alberro, Leire Iparraguirre, Adelaide Fernandes, David Otaegui
Extracellular Vesicles in Blood: Sources, Effects, and Applications. International journal of molecular sciences 22 (15) (2021)
Ander Egimendia, Susana Carregal-Romero, Iñaki Osorio-Querejeta, Daniel Padro, Jesús Ruíz-Cabello, David Otaegui, Pedro Ramos-Cabrer
Assessing the Potential of Molecular Imaging for Myelin Quantification in Organotypic Cultures. Pharmaceutics 13 (7) (2021)
Maider Muñoz-Culla, Andres Roncancio-Clavijo, Bruno Martínez, Miriam Gorostidi-Aicua, Luis Piñeiro, Arkaitz Azkune, Ainhoa Alberro, Jorge Monge-Ruiz, Tamara Castillo-Trivino, Alvaro Prada, David Otaegui
O group is a protective factor for COVID19 in Basque population. PloS one 16 (4) (2021)
Leire Iparraguirre, Ainhoa Alberro, Thomas B Hansen, Tamara Castillo-Triviño, Maider Muñoz-Culla, David Otaegui
Profiling of Plasma Extracellular Vesicle Transcriptome Reveals That circRNAs Are Prevalent and Differ between Multiple Sclerosis Patients and Healthy Controls. Biomedicines 9 (12) (2021)
Elia Gil-Varea, Maria Fedetz, Herena Eixarch, Nino Spataro, Luisa María Villar, Elena Urcelay, Albert Saiz, Óscar Fernández, Laura Leyva, Lluís Ramió-Torrentà, Koen Vandenbroeck, David Otaegui, Tamara Castillo-Triviño, Guillermo Izquierdo, Sunny Malhotra, Elena Bosch, Arcadi Navarro, Antonio Alcina, Xavier Montalban, Fuencisla Matesanz, Fuencisla Matesanz
A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells. Journal of clinical medicine 9 (3) (2020)
Paloma Gómez-Fernández, Aitzkoa Lopez de Lapuente Portilla, Ianire Astobiza, Jorge Mena, Andoni Urtasun, Vivian Altmann, Fuencisla Matesanz, David Otaegui, Elena Urcelay, Alfredo Antigüedad, Sunny Malhotra, Xavier Montalban, Tamara Castillo-Triviño, Laura Espino-Paisán, Orhan Aktas, Mathias Buttmann, Andrew Chan, Bertrand Fontaine, Pierre-Antoine Gourraud, Michael Hecker, Sabine Hoffjan, Christian Kubisch, Tania Kümpfel, Felix Luessi, Uwe K Zettl, Frauke Zipp, Iraide Alloza, Manuel Comabella, Christina M Lill, Koen Vandenbroeck
The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis. Cells 9 (1) (2020)
Olatz Arrizabalaga, David Otaegui, Itziar Vergara, Julio Arrizabalaga, Eva Méndez
Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMed. F1000Research 9 (2020)
Leire Iparraguirre, Danel Olaverri, Telmo Blasco, Lucía Sepúlveda, Tamara Castillo-Triviño, Mercedes Espiño, Lucienne Costa-Frossard, Álvaro Prada, Luisa María Villar, David Otaegui, Maider Muñoz-Culla
Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease. Biomedicines 8 (12) (2020)
Olatz Arrizabalaga, David Otaegui, Itziar Vergara, Julio Arrizabalaga, Eva Méndez
Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMed. F1000Research (2020)
Itziar Lopetegi, Amaia Muñoz-Lopetegi, Maialen Arruti, Alvaro Prada, Sabin Urcelay, Javier Olascoaga, David Otaegui, Tamara Castillo-Triviño
ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factor. Multiple sclerosis journal - experimental, translational and clinical 5 (4) (2019)

David Otaegui.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Otaegui